These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23991978)

  • 1. Bcl-2 gene expression in human breast cancers in iran.
    Rostamizadeh L; Fakhrjou A; Montazeri V; Estiar MA; Naghavi-Behzad M; Hosseini S; Sakhinia M; Sakhinia E
    Asian Pac J Cancer Prev; 2013; 14(7):4209-14. PubMed ID: 23991978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.
    André F; Michiels S; Dessen P; Scott V; Suciu V; Uzan C; Lazar V; Lacroix L; Vassal G; Spielmann M; Vielh P; Delaloge S
    Lancet Oncol; 2009 Apr; 10(4):381-90. PubMed ID: 19249242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESPL1 is a candidate oncogene of luminal B breast cancers.
    Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
    Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
    Luhtala S; Staff S; Tanner M; Isola J
    Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
    Duchnowska R; Jassem J; Goswami CP; Dundar M; Gökmen-Polar Y; Li L; Woditschka S; Biernat W; Sosińska-Mielcarek K; Czartoryska-Arłukowicz B; Radecka B; Tomasevic Z; Stępniak P; Wojdan K; Sledge GW; Steeg PS; Badve S
    J Neurooncol; 2015 Mar; 122(1):205-16. PubMed ID: 25559688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion.
    Petrović N; Mandušić V; Stanojević B; Lukić S; Todorović L; Roganović J; Dimitrijević B
    Med Oncol; 2014 Mar; 31(3):867. PubMed ID: 24488617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
    Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-inducible Gene-2 (MIG2) and migfilin expression is reduced in samples of human breast cancer.
    Gkretsi V; Papanikolaou V; Zacharia LC; Athanassiou E; Wu C; Tsezou A
    Anticancer Res; 2013 May; 33(5):1977-81. PubMed ID: 23645746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
    Reinholz MM; Iturria SJ; Ingle JN; Roche PC
    Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.
    Zhou W; Jiang Z; Liu N; Xu F; Wen P; Liu Y; Zhong W; Song X; Chang X; Zhang X; Wei G; Yu J
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):91-102. PubMed ID: 18670789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC35B2 expression is associated with a poor prognosis of invasive ductal breast carcinoma.
    Chim-ong A; Thawornkuno C; Chavalitshewinkoon-Petmitr P; Punyarit P; Petmitr S
    Asian Pac J Cancer Prev; 2014; 15(15):6065-70. PubMed ID: 25124574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
    Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.
    Litviakov NV; Cherdyntseva NV; Tsyganov MM; Slonimskaya EM; Ibragimova MK; Kazantseva PV; Kzhyshkowska J; Choinzonov EL
    Oncotarget; 2016 Feb; 7(7):7829-41. PubMed ID: 26799285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
    Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
    Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
    Yari K; Payandeh M; Rahimi Z
    Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
    Zaki SM; Abdel-Azeez HA; El Nagar MR; Metwally KA; S Ahmed MM
    Asian Pac J Cancer Prev; 2015; 16(3):1235-9. PubMed ID: 25735361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer.
    Yari K; Rahimi Z; Moradi MT; Rahimi Z
    Asian Pac J Cancer Prev; 2014; 15(15):6199-203. PubMed ID: 25124598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.